Supporting Research & Treatment of Childhood Brain Tumours
Brain tumours present a life changing experience. In children they are very rare, and unfortunately the prognosis is not very good. Current treatment involves Surgery, plus a combination of Chemotherapy and Radiotherapy, but each of these have devastating consequences in terms of side effects, both in the short term and over the long term. Research is trying to establish new innovative ways to treat childhood brain tumours, but this requires funding.
Skye was diagnosed with a brain tumour on 27 August 2013 and those close to him, are constantly in awe of his strength of character and fortitude in fighting a horrible disease. Cancer is so often thought of as an adult disease. Our experience has taught us otherwise.
Blue Skye Thinking is a Charity which supports research so that all children diagnosed with brain tumours, will have a better chance of survival and a better quality of life post treatment. The Charity is run by volunteers and all money donated goes directly to the forefront of Research and Treatment.
Researchers are making progress on a new approach to tackling brain tumours, which means an operation may not be necessary. Susan Short, professor of neuro-oncology at the University of Leeds, and Ed Jones, who was diagnosed with a terminal brain tumour in May 2012, discuss.
Blue Skye Thinking – The Rationale
The phrase ‘blue-sky thinking’ has the meaning of ‘thinking without limits’, ‘thinking outside of the box’, or even 'creative ideas that are not limited by current thinking, and unfettered by convention'. This is particularly pertinent when dealing with the complex nature of Cancer and it's treatment. Thinking is also clearly inextricably linked to the brain.
One of the real issues with Childhood Cancer is that it is rare, and that means there are fewer cases to work with in trying to find a cure. Researchers therefore, have to be resourceful when it comes to tackling the disease, and the reason why Blue Skye Thinking became the name of our Charity.